ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

イタリアでの星細胞腫診断・治療費用について今すぐご確認ください

料金はお問い合わせください
イタリアトルコオーストリア
開頭術から $25,000から $5,650から $20,000
定位放射線手術から $25,000から $4,500から $17,000
大腸癌に対する放射線療法から $7,000から $7,000から $12,000
乳癌化学療法から $4,500から $1,200から $15,000
ハルシオンから $11,500から $5,400-
データは2026年July月時点でBookimedにより検証され、世界130件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは星細胞腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。星細胞腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。星細胞腫治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 10/20/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

イタリアでの星細胞腫治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Which hospitals in Italy are best for astrocytoma and neuro-oncology?

Italy offers specialized neuro-oncology care at JCI-accredited facilities like Maria Cecilia Hospital. Leading centers in Milan and Bologna utilize advanced 4K 3D digital microscopes. These tools allow for precise tumor removal. Multi-disciplinary teams provide comprehensive surgical and radiation therapies for glial tumors.

  • Specialized technology: Centers use 4K 3D digital microscopes for minimally invasive astrocytoma resections.
  • Accreditation standards: Maria Cecilia Hospital holds Joint Commission International accreditation for neurosurgical safety.
  • Integrated treatment: Facilities offer stereotaxic radiosurgery alongside traditional craniotomy for complex brain tumors.
  • Patient capacity: Maria Cecilia Hospital treats 9,000 patients annually with a dedicated neurosurgery department.

Bookimed Expert Insight: Italian neuro-oncology centers like Maria Cecilia Hospital often specialize in heart-brain multidisciplinary cases. This expertise is vital for patients with secondary health risks. Our data shows that top centers prioritize 200+ specialist doctors on-site. This ensures immediate access to neuro-oncologists, neurologists, and surgeons for complex glioma management.

Patient Consensus: Patients emphasize choosing centers that offer both rapid imaging and molecular tumor testing. They note that the speed of pathology results is critical for starting adjuvant treatment.

What advanced technologies are used in Italy to remove brain tumors safely?

Italian neuro-oncology centers use real-time intraoperative MRI and fluorescence-guided surgery to remove brain tumors safely. These technologies help surgeons distinguish tumor margins from healthy tissue. Advanced facilities like Maria Cecilia Hospital utilize 4K 3D digital microsurgery to maintain precision through smaller incisions.

  • Intraoperative MRI: Scans the brain mid-surgery to identify residual tumor tissue immediately.
  • Fluorescence guidance: Uses 5-ALA compounds to make tumor cells glow under microscopes.
  • Neuronavigation systems: Acts as GPS to guide surgical instruments away from critical zones.
  • Awake craniotomy: Enables functional mapping of speech and motor centers during active resection.
  • CyberKnife M6: Delivers robotically guided radiation that adjusts to a patient's natural breathing.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital specialize in neurosurgery and maintain JCI accreditation for safety. Data shows these high-volume facilities often utilize a multimodal setup combining 3D digital endoscopes with real-time neurophysiological monitoring. This integrated approach is more effective than any single device for complex astrocytoma cases.

Patient Consensus: Patients value the multidisciplinary team approach and often feel reassured when awake mapping is used. They frequently highlight the importance of intraoperative imaging to ensure as much tumor as possible is removed safely.

Are non-surgical options like stereotactic radiosurgery and advanced radiotherapy available for astrocytomas in Italy?

Non-surgical options for astrocytomas are widely available in Italy. Leading oncology centers utilize stereotactic radiosurgery (SRS) and advanced radiotherapy. Systems like Gamma Knife and CyberKnife provide sub-millimeter precision. Italian facilities are highly integrated with European clinical safety networks for brain tumor care.

  • Available technologies: Centers utilize Gamma Knife, CyberKnife, and TrueBeam STx systems.
  • Particle therapy: Specialized facilities offer proton and carbon ion therapy.
  • Precision targeting: Stereotactic radiosurgery treats localized or recurrent astrocytomas non-invasively.
  • Accredited care: Many Italian centers hold Joint Commission International (JCI) accreditation.

Bookimed Expert Insight: Italian neuro-oncology is highly centralized. Major research hospitals like Maria Cecilia Hospital often hold specialized rankings. This clinic was ranked best for neurosurgery by Bookimed patients. Facilities with over 200 doctors typically offer broader multidisciplinary teams. These teams are essential for matching treatment to a tumor's genetic profile. Focus on centers with over 14 departments to ensure comprehensive care.

Patient Consensus: Patients note that advanced treatment access depends heavily on the specific hospital. Large university centers are often better equipped for complex precision radiotherapy than local facilities.

Can patients receive targeted therapies or enroll in clinical trials for IDH-mutant astrocytomas in Italy?

Patients in Italy can access targeted therapies like Vorasidenib and enroll in clinical trials for IDH-mutant astrocytomas. Access is managed through the Italian Medicines Agency (AIFA). Major JCI-accredited research hospitals in Milan, Rome, and Bologna offer dual IDH1/IDH2 inhibitors and international research protocols.

  • Targeted medications: Vorasidenib is EMA-approved for Grade 2 IDH-mutant astrocytomas in adult patients.
  • Advanced access: Law 648/96 allows doctors to request early access to medications before reimbursement.
  • Clinical research: Italian sites participate in the EORTC-2427 trial for Grade 2 and 3 tumors.
  • Molecular testing: Centers perform precise molecular profiling for IDH1, IDH2, and 1p/19q codeletion status.

Bookimed Expert Insight: Clinical trial availability in Italy changes monthly across different regions. Large JCI-accredited facilities like Maria Cecilia Hospital in Bologna specialize in complex neurosurgery and research. Patients should prioritize centers with multidisciplinary tumor boards. These boards can approve off-label inhibitors like Ivosidenib when genomic profiling justifies the usage.

Patient Consensus: Patients emphasize obtaining a full molecular diagnosis early to qualify for trials. Many recommend seeking a second opinion at major university hospitals if local clinics lack experimental protocols.

Do leading Italian hospitals accept international patients for astrocytoma treatment?

Leading Italian hospitals actively accept international patients for astrocytoma treatment through dedicated international departments. Specialized centers provide advanced neuro-oncology care. They offer microsurgery, brain mapping, and radiosurgery. Facilities often hold JCI accreditation. They coordinate medical visas and language translation for foreign nationals.

  • Surgical precision: Surgeons use 4K 3D digital microscopes for precise tumor resection.
  • Advanced modalities: Facilities offer specialized treatments like Gamma Knife and Tomotherapy.
  • Specialized monitoring: Intraoperative neurophysiological monitoring helps preserve vital cognitive and speech functions.
  • Research status: Many centers hold IRCCS scientific status, providing access to clinical trials.

Bookimed Expert Insight: Italian centers specializing in neurosurgery are highly concentrated in the north. Maria Cecilia Hospital performs over 1,000 complex procedures annually. It is situated just 40 minutes from Bologna International Airport. This proximity is vital for recovery. Patients should look for hospitals with JCI accreditation. These facilities often maintain higher volume ratings for complex neurosurgery.

Patient Consensus: Patients note that admission is not automatic and requires a thorough record review. It is essential to provide complete MRI scans and pathology reports before traveling.

How does insurance or health-service coverage work for foreign astrocytoma patients in Italy?

Coverage for astrocytoma in Italy depends on residency and home country. Legal residents access the state system for a fixed title. European Union citizens use health cards for emergencies. Non-residents usually pay out of pocket or use private insurance for planned neurosurgery.

  • Residency status: Legal residents register with state health services for full cancer coverage.
  • EU patients: European Health Insurance Cards cover emergency stabilization but not planned operations.
  • Therapeutic exemptions: Diagnosed patients receive codes to waive costs for MRIs and chemotherapy.
  • Private options: Private hospitals like Maria Cecilia Hospital accept self-pay patients for advanced neurosurgery.

Bookimed Expert Insight: While Italy offers public coverage, the 9,000 annual patients at centers like Maria Cecilia Hospital often choose private care to bypass wait times. This is vital for astrocytoma where surgical timing affects outcomes. Specialized facilities frequently hold Joint Commission International accreditation which ensures safety standards for complex brain tumor removals.

Patient Consensus: Patients note that public registration involves heavy paperwork but eventually eliminates most medication costs. Many recommend bringing organized pathology records to speed up the required second opinions before surgery.

無料相談を受ける

最適な連絡方法をお選びください